Bob Yedid, a healthcare industry veteran with over 20 years of experience, has joined ICR Inc., one of the largest companies in strategic financial communications. Bob has a strong track record in public company investing, private equity, investment banking, and portfolio management. Bob holds an MBA in Finance and General Management from Stanford Graduate School of Business, as well as a Bachelor's degree in Economics, magna cum laude, from Yale University.
Bob has a deep knowledge of all the significant sectors of healthcare and has worked with private and public healthcare companies, providing strategic counsel for investor relations. Bob's documented record of significant outperformance in health care investing includes time as the senior analyst and portfolio manager at health care equities at Principled Capital and Hillhouse Capital. He has also served on the Board of Directors of public and private companies, including The Medicines Company and Eurand International.
In his most recent role, Bob served as a consultant at Broadfin Capital. Prior to this, he held several senior positions, such as a Portfolio Manager at Hillhouse Capital Management and Managing Partner at Hillhouse Capital Management. Additionally, Bob served as a Managing Director at Bear Stearns and a Director of Investment Banking at Salomon Brothers.
Bob's specialties in the healthcare industry include investor relations for companies in medical technology, diagnostics, biotech, specialty pharmaceuticals, and healthcare information technology or healthcare services.